Serving size is 1 Tablet(s), with 400 servings per container and $0.05 per serving
This controlled "off-ramp" is a much safer and more effective strategy for long-term success
EU-licensed doctors Every case is reviewed by a licensed clinician
Other programs Generic, one-size-fits-all approaches Quick online assessment Private NAD+ Injectable therapy available by prescription through licensed providers NAD+ Injectable therapy available by prescription through licensed providers Answer a few quick questions and we'll help you find the right treatment Takes a few minutes Private Always free Compounded Tirzepatide (GLP-1/GIP) From $183/month No membership required
These include the cost of the medication, potential side effects such as gastrointestinal disturbances and increased risk of thyroid tumors, the unestablished long-term safety in non-diabetic individuals, and limited availability due to high demand
Results announced in October 2025 demonstrated orforglipron's superiority on both HbA1c and weight endpoints, positioning it as a more effective second-line oral agent than existing oral diabetes medications